Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 1

3(60.0%)

Phase 4

1(20.0%)

N/A

1(20.0%)

5Total

Phase 1(3)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05487417Phase 4Recruiting

Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

Role: collaborator

NCT06863831Not ApplicableEnrolling By Invitation

A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC

Role: collaborator

NCT06683066Phase 1Recruiting

Study on Human Bioequivalence of Triprerelin Acetate for Injection

Role: collaborator

NCT06392503Recruiting

Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis

Role: collaborator

NCT05956847Recruiting

The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric

Role: collaborator

NCT05364047Phase 1Unknown

Clinical Trial of SARS-CoV-2 mRNA Vaccine in China

Role: collaborator

NCT05273944Phase 1Unknown

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Role: collaborator

NCT04020536Recruiting

Real World Study of Classic Infectious Disease

Role: collaborator

All 8 trials loaded